Get the Stockscreener App
0.4551
6.22%
-0.0302
Intensity Therapeutics Inc stock is traded at $0.4551, with a volume of 5.66M.
It is down -6.22% in the last 24 hours and up +61.38% over the past month.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
See More
Previous Close:
$0.4853
Open:
$0.49
24h Volume:
5.66M
Relative Volume:
0.20
Market Cap:
$22.33M
Revenue:
-
Net Income/Loss:
$-16.26M
P/E Ratio:
-0.3852
EPS:
-1.1814
Net Cash Flow:
$-13.50M
1W Performance:
-37.67%
1M Performance:
+61.38%
6M Performance:
-17.43%
1Y Performance:
-85.87%
1-Day Range:
$0.4301
$0.5027
1-Week Range:
$0.4301
$0.7072
52-Week Range:
$0.1853
$3.3985
Intensity Therapeutics Inc Stock (INTS) Company Profile
Name
Intensity Therapeutics Inc
Sector
Industry
Phone
203-221-7381
Address
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.4551 | 29.12M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Intensity Therapeutics Inc Stock (INTS) Latest News
Ranking Intensity Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & Target Return Focused Picks - newser.com
How to track smart money flows in Intensity Therapeutics Inc.Weekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
Will Intensity Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Intensity Therapeutics Shrinks Losses As Cash Runway Extends - Finimize
How Intensity Therapeutics Inc. stock trades before earningsMarket Trend Review & Weekly Hot Stock Watchlists - newser.com
Intensity Therapeutics Q3 net loss narrows to $2.7 mln - MarketScreener
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire
Will Intensity Therapeutics Inc. stock reach all time highs in 2025Market Trend Review & Precise Buy Zone Tips - newser.com
Does Intensity Therapeutics Inc. show high probability of reboundSwing Trade & Expert Curated Trade Setups - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Will Intensity Therapeutics Inc. rebound enough to break evenMarket Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com
Is Intensity Therapeutics Inc. stock oversold or undervaluedEarnings Recap Summary & High Return Stock Watch Alerts - newser.com
How supply chain issues affect Intensity Therapeutics Inc. stockMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
How Intensity Therapeutics Inc. stock performs in stagflation2025 Price Targets & Long-Term Capital Growth Strategies - newser.com
How interest rate cuts could boost Intensity Therapeutics Inc. stockJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Volume spikes in Intensity Therapeutics Inc. stock – what they meanWeekly Trend Report & Verified Technical Trade Signals - newser.com
Is Intensity Therapeutics Inc. stock trading near support levelsJuly 2025 Pullbacks & Verified Entry Point Signals - fcp.pa.gov.br
How to integrate Intensity Therapeutics Inc. into portfolio analysis toolsPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Will a bounce in Intensity Therapeutics Inc. offer an exitBuy Signal & Free Accurate Trade Setup Notifications - newser.com
Why Intensity Therapeutics Inc. stock is favored by top institutions2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Intensity Therapeutics Inc Stock (INTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):